Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic
  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Enfusion Announces Third Quarter 2023 Results

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, has posted its third quarter 2023 financial results as part of its 3Q 2023 Shareholder Letter which can be viewed here or by navigating to the Financials section of its Investor Relations website which can be found at http://ir.enfusion.com.

3Q23 Earnings Conference Call

Management will host a conference call today, November 7, 2023, at 8:30 am ET to discuss the results.

To pre-register for the live teleconference of the third quarter earnings call, please use this link. To access this call, dial (888) 330-2502. The conference ID number is 61821.

The earnings conference call will also be webcast live. Due to high call volumes, we urge interested parties to join the live webcast of the event through Enfusion’s website at https://ir.enfusion.com/events-and-presentations/events/default.aspx.

About Enfusion

Enfusion's investment management software-as-a-service (SaaS) platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with over 800 investment managers from 10 global offices spanning four continents.

Source: Enfusion, Inc.

Source Code: ENFN-IR

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.